Subtypes of functional α1- and α2-adrenoceptors

European Journal of Pharmacology

Volumn 361, Issue 1, 1998, Pages 1-15

  Docherty, James R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

1 Adrenoceptor; 2 Adrenoceptor; Postjunctional receptor; Prejunctional receptor

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA 2D ADRENERGIC RECEPTOR; CALCIUM ION; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; MEMBRANE RECEPTOR; NORADRENALIN; POTASSIUM CHANNEL; RECEPTOR SUBTYPE;

CALCIUM TRANSPORT; ENZYME INHIBITION; HUMAN; MUSCLE CONTRACTION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SMOOTH MUSCLE CONTRACTION; CLASSIFICATION; PHYSIOLOGY;

HUMANS; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0031593630     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00682-7     Document Type: Review

References (175)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen. Br. J. Pharmacol. 109:1993;80-87.
2. Ahlquist R.P. A study of the adrenotropic receptors. Am. J. Physiol. 153:1948;586-600.
3. 2-Adrenoceptor blocking profile of SK and F 104078: further evidence for receptor subtypes. Br. J. Pharmacol. 102:1991;943-949.
4. 2-adrenoceptor mediated effects on noradrenaline release. Naunyn-Schmiedeberg's Arch. Pharmacol. 333:1986;104-109.
5. Andersson K.-E., Wagner G. Physiology of penile erection. Physiol. Rev. 75:1995;192-236.
6. Bacq Z.M., Frederico H. Action adrenolytique d'un derive de dioxane (933F). Comptes Rendues Societe Belge de Biologie. 117:1934;806-808.
7. Berthelsen S., Pettinger W.A. A functional basis for classification of a-adrenergic receptors. Life Sci. 21:1977;595-606.
8. Blaylock N.A., Wilson V.G. Pharmacological characterization of noradrenaline-induced contractions of the porcine isolated palmer lateral vein and palmer common digital artery. Br. J. Pharmacol. 114:1995;694-702.
9. Bognar T.I., Baretti R., Fischer S., Veldet C., Fuder H. Alpha-adrenoceptor mediated facilitation of acetylcholine release in rat perfused heart. J. Pharmacol. Exp. Ther. 254:1990;702-710.
10. 2-Autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation. Br. J. Pharmacol. 108:1993;262-268.
11. Borton M., Docherty J.R. The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;130-135.
12. Boyer J.L., Cardenas C., Posadas C., Garcia-Sainz J.A. Pertussis toxin induces tachycardia and impairs the increase in blood pressure produced by alpha2-adrenergic agonists. Life Sci. 33:1983;2627-2633.
13. Brown G.L., Gillespie J.S. The output of sympathetic transmitter from the spleen of the cat. J. Physiol. 138:1957;81-102.
14. Browne I., Thomas G., Gavin K., Docherty J.R. Prejunctional actions of N-ethyl-maleimide and phenoxybenzamine in rat vas deferens. Eur. J. Pharmacol. 265:1994;125-132.
15. 2-adrenoceptors in the mouse vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 343:1991;623-632.
16. 1B-adrenoceptor mediating contraction of the rat spleen. Br. J. Pharmacol. 115:1995;467-475.
17. 2+ influx stimulated by diacylglycerol and PKC. Br. J. Pharmacol. 123:1998;317-325.
18. Bylund D.B. Heterogeneity of alpha-2 adrenergic receptors. Pharmacol. Biochem. Behav. 22:1985;835-843.
19. 2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol. Sci. 9:1988;356-361.
20. 2-adrenergic receptors. FASEB J. 6:1992;832-839.
21. Bylund D.B., Eikenberg D.C., Heible J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R., Trendelenburg U. IV. International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46:1994;121-136.
22. Caine M. The present role of α-adrenergic blockers in the treatment of benign prostatic hypertrophy. J. Urol. 136:1986;1-4.
23. Cavalli A., Lattion A., Hummler E., Nenninger M., Pedrazzini T. Decreased blood pressure response in mice deficient of the alpha 1b-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 94:1997;11589-11595.
24. 1-adrenoceptor. Br. J. Pharmacol. 119:1996;1093-1100.
25. Connaughton S., Docherty J.R. Evidence that SK and F 104078 does not differentiate between pre- and postjunctional alpha-2 adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;379-382.
26. 2-adrenoceptors. Br. J. Pharmacol. 101:1990;285-290.
27. 1-adrenergic receptor. Proc. Natl. Acad. Sci USA. 85:1988;7159-7163.
28. Daly C.J., Cotecchia S., McGrath J.C. Low frequency electrical field stimulation elicits responses in segments of mouse tail artery which are slower in alpha1B-knockout mice than in control mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;R600.
29. Daniel E.E., Gaspar V., Berezin I., Kwan C.Y. Characterization of alpha2 adrenoceptors and other adrenoceptors in membranes isolated from dog mesenteric nerve axons. J. Pharmacol. Exp. Ther. 275:1995;978-986.
30. Davis J.P.L., Harper A.A., Chipperfield A.R. Stimulation of intracellular chloride accumulation by noradrenaline and hence potentiation of its depolarization of rat arterial smooth muscle in vitro. Br. J. Pharmacol. 122:1997;639-642.
31. de Groat W.C., Booth A.M. Inhibition and facilitation in parasympathetic ganglia. Fed. Proc. 39:1980;2990-2996.
32. 2+ current inhibition by neurotransmitters in rat sympathetic neurones. J. Physiol. 506:1998;319-329.
33. Docherty J.R. An investigation of presynaptic alpha-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens. Br. J. Pharmacol. 82:1984;15-23.
34. 2-adrenoceptors in rat heart and vas deferens. J. Auton. Pharmacol. 8:1988;197-201.
35. Docherty J.R. The effects of ageing on vascular alpha-adrenoceptors in pithed rat and rat aorta. Eur. J. Pharmacol. 146:1988;1-5.
36. 2-adrenoceptors: evidence for and against a further subdivision. Pharmacol. Ther. 44:1989;241.
37. Docherty J.R. Cardiovascular responses in ageing: a review. Pharmacol. Rev. 42:1990;103-125.
38. Docherty J.R. No effect of pertussis toxin on peripheral prejunctional alpha-2 adrenoceptor mediated responses and on endothelium-dependent relaxations in the rat. Br. J. Pharmacol. 100:1990;348-352.
39. Docherty J.R. Effects of ageing on the vasoconstrictor responses to noradrenaline and 5-hydroxytryptamine in the human saphenous vein. Cardiol. Elderly. 1:1993;327-330.
40. Docherty J.R. Alpha-adrenoceptors: from theoretical concept to molecular visualisation. Ir. J. Med. Sci. 163:1994;4-8.
41. 1-adrenoceptor in rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;R612.
42. + channel blockers in rat vas deferens. Eur. J. Pharmacol. 287:1995;287-293.
43. 2-adrenoceptors can mediate nerve stimulation-evoked contractions. Clin. Sci. 68(Suppl. 10):1985;117s-120s.
44. Docherty J.R., McGrath J.C. A comparison of pre- and postjunctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat: evidence for two types of postjunctional alpha-adrenoceptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 312:1980;107-116.
45. Docherty J.R., MacDonald A., McGrath J.C. Further subclassification of alpha-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus muscle of the rat. Br. J. Pharmacol. 67:1979;421P.
46. Drew G.M. What do antagonists tell us about α-adrenoceptors? Clin. Sci. 68:1985;15s-19s. Suppl. 10.
47. Drew G.M., Whiting S.B. Evidence for two distinct types of postsynaptic α-adrenoceptor in vascular smooth muscle in vivo. Br. J. Pharmacol. 67:1979;207-215.
48. Eltze M. Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen. Eur. J. Pharmacol. 311:1996;187-198.
49. Eltze M. In functional experiments, risperidone is selective, not for the B, but for the A subtype of alpha-1 adrenoceptor. Eur. J. Pharmacol. 295:1996;69-73.
50. Eskinder H., Hillard C.J., Olinger G.N., Christensen C.W., Baker J.E., Warltier D.C., Gross G.J. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin. J. Pharmacol. Exp. Ther. 247:1988;941-948.
51. Exton J.H. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36:1996;481-509.
52. 1-adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta. Br. J. Pharmacol. 120:1997;247-258.
53. Feuvrier E., Aubert M., Mausset A.L., Alonso G., Gaillet S., Malaval F., Szafarczyk A. Glucocorticoids provoke a shift from alpha2- to alpha1-adrenoceptor activities in cultured hypothalamic slices leading to opposite noradrenaline effect on corticotropin-releasing hormone release. J. Neurochem. 70:1998;1199-1209.
54. 1-Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci. 7:1986;347-349.
55. 1-adrenoceptors in isolated anococcygeus muscle of rat. Br. J. Pharmacol. 109:1993;112P.
56. 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol. Pharmacol. 49:1996;209-215.
57. 1-adrenoceptor classification. Br. J. Pharmacol. 121:1997;137-1135.
58. 1A-Adrenoceptor-mediated contractile responses of the human vas deferens. Br. J. Pharmacol. 116:1995;1605-1610.
59. Furuya S., Kumamoto Y., Yokoyama E., Tsukamoto T., Izumi T., Abiko Y. Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J. Urol. 128:1982;836-839.
60. 2-adrenoceptor mediating pressor responses in the pithed rat. Eur. J. Pharmacol. 318:1996;81-87.
61. 2C-Adrenoceptors mediate contractile responses to noradrenaline in the human saphenous vein. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;406-411.
62. 1-adrenoceptors. Eur. J. Pharmacol. 272:1995;R5-R6.
63. Gu H., Trajkovic S., LaBelle E.F. Norepinephrine-induced phosphatidylcholine hydrolysis by phospolipases D and C in rat tail artery. Am. J. Physiol. 262:1992;C1376-C1383.
64. Gupta S., Moreland R.B., Yang S., Gallant C.M., Goldstein I., Traish A. The expression of functional postsynaptic a2-adrenoceptors in the corpus cavernosum smooth muscle. Br. J. Pharmacol. 123:1998;1237-1245.
65. 2+ in smooth muscle. Nature. 329:1987;333-335.
66. 2-adrenoceptors. Trends Pharmacol. Sci. 12:1991;62-67.
67. Haynes J.M., Hill S.J. α-Adrenoceptor mediated responses of the cauda epididymis of the guinea-pig. Br. J. Pharmacol. 119:1996;1203-1210.
68. 2-Adrenoceptors in the guinea-pig uterus: heterogeneity in the circular and longitudinal smooth muscle layers. Eur. J. Pharmacol. 250:1993;231-237.
69. Hein L., Kobilka B.K. Clinical and molecular pharmacology of adrenergic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;R575.
70. Heise A., Kroneberg G., Schlossman K. α-Sympathicomimetische eigenschaften als ursache der blutdruckssteigernden und blutdruckenkenden wirkung von BAY 1470. Naunyn-Schmiedeberg's Arch. Pharmacol. 268:1971;348-360.
71. Hicks P.E., Barras M., Herman G., Mauduit P., Armstrong J.M., Rossignol B. α-Adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production. Br. J. Pharmacol. 102:1991;151-161.
72. 1-adrenoceptors: consensus update. Pharmacol. Rev. 47:1995;267-270.
73. 2-adrenoceptor mediating prejunctional inhibition in rat atrium and cerebral cortex. Naunyn-Schmeideberg's Arch. Pharmacol. 357:1998;634-639.
74. Hunter J.C., Fontana D.J., Hedley L.R., Japser J.R., Lewis R., Link R.E., Secchi R., Sutton J., Eglen R.M. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br. J. Pharmacol. 122:1997;1339-1344.
75. 1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br. J. Pharmacol. 122:1997;849-858.
76. Kaschube M., Brasch H. Pre- and postjunctional effects of N-ethylmaleimide in the isolated mouse vas deferens. Eur. J. Pharmacol. 178:1990;151-159.
77. 1L-Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br. J. Pharmacol. 123:1998;1359-1366.
78. 2-adrenoceptors. Am. J. Physiol. 258:1990;R44-R50.
79. 1-adrenoceptors: binding, functional and in vivo studies. Br. J. Pharmacol. 118:1996;871-878.
80. 2-adrenoceptors from GTP-binding proteins by N-ethylmaleimide. J. Neurochem. 49:1987;1894-1901.
81. 1A receptor subtype. J. Pharmacol. Exp. Ther. 274:1995;97-103.
82. Kobinger W., Pichler L. Investigations into different types of post and presynaptic α-adrenoceptors at cardiovascular sites in rats. Eur. J. Pharmacol. 65:1980;393-402.
83. 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br. J. Pharmacol. 120:1997;819-826.
84. Langer S.Z. Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23:1974;1793-1800.
85. Langer S.Z. 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol. Sci. 18:1997;95-99.
86. 2-adrenoceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb. Clin. Sci. 59:1981;225s-228s. Suppl. 6.
87. 2-adrenergic receptor. J. Biol. Chem. 266:1991;10470-10478.
88. Leech C.J., Faber J.E. Different α-adrenoceptor subtypes mediate constriction of arterioles and venules. Am. J. Physiol. 270:1996;H710-H722.
89. 1-adrenoceptor antagonists in the lower urinary tract. Br. J. Pharmacol. 109:1993;1282-1289.
90. 2-autoreceptors in rat submaxillary gland and heart atrium. Br. J. Pharmacol. 107:1992;246-255.
91. Link R.E., Desai K., Hein L., Stevens M.E., Chruscinski A., Bernstein D., Barsh G.S., Kobilka B.K. Cardiovascular regulation in mice lacking alpha sub 2-adrenergic receptor subtypes b and c. Science. 273:1996;803-806.
92. 1A-adrenergic receptor. J. Biol. Chem. 266:1991;6365-6369.
93. 2-receptor classification. Mol. Pharmacol. 38:1990;599-603.
94. MacGilchrist A.J., Hawksby C., Howes L.G., Reid J.L. Rise in plasma noradrenaline with age results from an increase in spillover rate. Gerontology. 35:1989;7-13.
95. 2-adrenoceptors mediating contraction of dog saphenous vein: identity with human 2A subtype. Br. J. Pharmacol. 121:1997;1721-1729.
96. MacMillan L.B., Hein L., Smith M.S., Piascik M.T., Limbird L.E. Central hypotensive effects of the alpha sub 2a-adrenergic subtype. Science. 273:1996;801-803.
97. 1-Adrenergic stimulation of platelet-derived growth factor signal transduction. Science. 270:1990;296-299.
98. 1c-) adrenoceptor subtype. Br. J. Pharmacol. 115:1995;781-786.
99. 2-adrenoceptor subtypes. Mol. Pharmacol. 44:1993;1165-1170.
100. Miller R.J. Presynaptic receptors. Annu. Rev. Pharmacol. Toxicol. 38:1998;201-207.
101. 2+. Pharmacol. Rev. 40:1988;87-119.
102. 2-adrenoceptors in the rabbit pulmonary artery and human saphenous vein. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;483-490.
103. 1-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions. Br. J. Pharmacol. 122:1997;1009-1014.
104. 3H ]prazosin binding Mol. Pharmacol. 29:1986;321-330.
105. Muller-Schweinitzer E. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins. Naunyn-Schmiedeberg's Arch. Pharmacol. 327:1984;299-303.
106. 1-adrenoceptors in vascular smooth muscle. Br. J. Pharmacol. 99:1990;197-201.
107. 1-adrenoceptor subtypes in the human prostate: functional and binding studies. Br. J. Urol. 74:1995;572-578.
108. 2-adrenoceptors in mouse atria function through G-proteins which are sensitive to N-ethylmaleimide, but not pertussis toxin. Br. J. Pharmacol. 106:1992;871-876.
109. 2-adrenoceptor mediated inhibition of noradrenaline release in mouse atria. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;280-286.
110. 2-adrenergic receptor subtype involved in the release of insulin from rat isolated pancreatic islets. J. Pharmacol. Exp. Ther. 254:1990;883-887.
111. 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br. J. Pharmacol. 121:1997;665-670.
112. 1D-adrenoceptor subtypes. Br. J. Pharmacol. 120:1997;231-238.
113. 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br. J. Pharmacol. 107:1992;698-704.
114. 2-adrenoceptors. Pharmacology. 43:1991;1-13.
115. O'Rourke M., Kearns S., Docherty J.R. Investigations of the actions of chloroethylclonidine in rat aorta. Br. J. Pharmacol. 115:1995;1399-1406.
116. O'Rourke M., Gavin K., Docherty J.R. Further investigation of the α-adrenoceptor mediated actions of chloroethylclonidine in rat aorta. Eur. J. Pharmacol. 336:1997;37-42.
117. 2-adrenoceptors in human isolated subcutaneous resistance arteries. Br. J. Pharmacol. 115:1995;1463-1468.
118. 3H ]noradrenaline release in rat brain cortical and hippocampal synaptosomes Neurosci. Lett. 216:1996;187-190.
119. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 40:1991;876-883.
120. 1D-adrenergic receptors to multiple signaling pathways is both G-protein and cell type specific. Mol. Pharmacol. 44:1993;784-795.
121. 1-Adrenoceptor subtypes and the regulation of peripheral hemodynamics in the conscious rat. Eur. J. Pharmacol. 186:1990;273-278.
122. Piascik M.T., Guarino R.D., Smith M.S., Soltis E.E., Saussy D.L., Perez D.M. The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther. 275:1995;1583-1589.
123. Raffa R.B., Connelly C.D., Chambers J.R., Stone D.J. Alpha-subunit G-protein antisense oligonucleotide effects on supraspinal (i.c.v.) alpha2-adrenoceptor antinociception in mice. Life Sci. 58:1996;77-80.
124. 2-autoreceptors in human brain cortex. Br. J. Pharmacol. 107:1992;1146-1151.
125. 2-adrenoceptors in the vasculature of the rat tail. Br. J. Pharmacol. 114:1995;1724-1730.
126. 2-adrenoceptor antagonist in the human saphenous vein in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;327-332.
127. Ruan Y., Kan H., Parmentier J.-H., Fatima S., Allen L.F., Malik K.U. Alpha-1A adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase D in rat-1 fibroblasts: inhibition by protein kinase A. J. Pharmacol. Exp. Ther. 284:1998;575-585.
128. 2-adrenoceptors by SF and F 104078. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;415-418.
129. 2-adrenoceptors in rat isolated kidney. J. Cardiovasc. Pharmacol. 9:1987;500-507.
130. 2-adrenoceptors inhibits noradrenaline release in rabbit renal arteries: effects of pertussis toxin and N-ethylmaleimide. J. Auton. Pharmacol. 12:1992;97-108.
131. 2C-Adrenoceptor-modulated release of noradrenaline in human right atrium. Br. J. Pharmacol. 116:1995;2617-2624.
132. Sallinen J., Link R.E., Haapalinna A., Viitamaa T., Kulatunga M., Sjoholm B., MacDonald E., Pelto-Huikko M., Leino T., Barsh G.S., Kobilka B.K., Scheinin M. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype- nonselective alpha2-adrenoceptor agonist. Mol. Pharmacol. 51:1997;36-46.
133. Schwartz D.D. Activation of alpha-2 adrenergic receptors inhibits norepinephrine release by a pertussis toxin-insensitive pathway independent of changes in cytosolic calcium in cultured rat sympathetic neurones. J. Pharmacol. Exp. Ther. 282:1997;248-255.
134. 1-adrenergic receptor subtype. J. Biol. Chem. 265:1990;8183-8189.
135. 1a-Adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br. J. Pharmacol. 118:1996;1403-1408.
136. Shinozuka K., Kunitomo M., Bjur R.A., Westfall D.P., Hattori K. Effect of methoxamine on noradrenaline release in the caudal artery of hypertensive rats. Clin. Exp. Pharmacol. Physiol. 22(Suppl. 1):1995;S88-S90.
137. Sleight A.J., Koek W., Bigg D.C. Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors. Eur. J. Pharmacol. 238:1993;407-410.
138. 2D-subtype? Eur. J. Pharmacol. 219:1992;203-210.
139. 2-adrenoceptors in rat atrium, vas deferens and submandibular gland. Eur. J. Pharmacol. 211:1992;251-256.
140. 2-adrenoceptor mediating contraction of the human saphenous vein. Br. J. Pharmacol. 106:1992;447-451.
141. 2-adrenoceptor mediating prejunctional inhibition of cardio-acceleration in the pithed rat heart. Br. J. Pharmacol. 115:1995;316-320.
142. 1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries. Br. J. Pharmacol. 122:1997;825-832.
143. Somogyi G.T., Tanowitz M., de Groat W.C. Prejunctional facilitatory alpha-1 adrenoceptors in the rat urinary bladder. Br. J. Pharmacol. 114:1995;1710-1716.
144. 1 muscarinic receptor-induced facilitation of ACh and noradrenaline release in the rat bladder is mediated by protein kinase C. J. Physiol. 496:1996;245-254.
145. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77:1977;1-124.
146. Starke K. Presynaptic-autoreceptors. Rev. Physiol. Biochem. Pharmacol. 107:1987;73-146.
147. Starke, K., Langer, S.Z., 1979. A note on the terminology for presynaptic receptors. In: Langer, S.Z., Starke, K., Dubocovich, M.L. (Eds.), Presynaptic Receptors. Pergamon, Oxford, pp. 1-3.
148. Starke K., Montel H., Schumann J.J. Influence of cocaine and phenoxybenamine on noradrenaline uptake and release. Naunyn-Schmiedeberg's Arch. Pharmacol. 274:1971;18-45.
149. Starke K., Wagner J., Schumann J.J. Adrenergic neurone blockade with clonidine: comparison with guanethidine and local anaesthetics. Influence of cocaine and phenoxybenamine on noradrenaline uptake and release. Arch. Int. Pharmacodyn. Ther. 195:1972;291-308.
150. Steen S., Sjoberg T., Skarby T., Norgren L., Andersson K.-E. The postjunctional α-adrenoceptors of the human saphenous vein. Acta Pharmacol. Toxicol. 55:1984;351-357.
151. Stone L.S., MacMillan L.B., Kitto K.E., Limbird L.E., Wilcox G.L. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha-2 agonists and is necessary for spinal adrenergic-opioid synergic. J. Neurosci. 17:1997;7157-7165.
152. Svensson S.P., Bailey T.J., Porter A.C., Richman J.G., Regan J.W. Heterologous expression of the cloned guinea pig alpha 2A, alpha 2B, and alpha 2C adrenoceptor subtypes. Radioligand binding and functional coupling to a cAMP-responsive reporter gene. Biochem. Pharmacol. 51:1996;291-300.
153. Tabernero A., Vila E. Effect of age on noradrenaline response in tail artery and aorta: role of endothelium. J. Auton. Pharmacol. 15:1995;327-333.
154. 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen. Eur. J. Pharmacol. 265:1994;61-66.
155. Thoenen H., Hurlimann A., Haefely W. Wirkungen von phenoxybenzamin, phentolamine und azapetin auf adrenergische synapsen der katzenmilz. Helv. Physiol. Pharmacol. Acta. 22:1964;148-161.
156. 2A in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:1993;35-45.
157. 2C-subtype mediate inhibition of norepinephrine release in human kidney cortex. Mol. Pharmacol. 45:1994;1168-1176.
158. 2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;721-737.
159. 2-adrenoceptors in blood vessels: effects of age. Eur. J. Pharmacol. 237:1993;311-316.
160. 2-adrenoceptor Br. J. Pharmacol. 106:1992;986-995.
161. 1-adrenoceptor antagonists on noradrenaline-mediate contraction of rat small mesenteric artery. Br. J. Pharmacol. 118:1996;1308-1316.
162. Villalobos-Molina R., Ibarra M. Alpha 1-adrenoceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the alpha1D or alpha 1A subtypes. Eur. J. Pharmacol. 298:1996;257-263.
163. Villalobos-Molina R., Lopez-Guerrero J.J., Ibarra M. Alpha 1D- and alpha-1A-adrenoceptors mediate contraction in rat renal artery. Eur. J. Pharmacol. 322:1997;225-227.
164. Wada T., Hasegawa Y., Ono H. Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity. Eur. J. Pharmacol. 340:1997;45-52.
165. Wahl C.A., Trendelenburg A.U., Starke K. Presynaptic alpha-2 autoreceptors in mouse heart atria: evidence for the alpha 2D subtype. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;253-261.
166. 2-adrenoceptors at the terminals of perivascular sympathetic nerves are coupled to an N-ethylmaleimide-sensitive G-protein. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;R35.
167. Westfall T.C. Local regulation of adrenergic neurotransmission. Physiol. Rev. 57:1977;659-728.
168. Wright I.K., Harling R., Kendall D.A., Wilson V.G. Examination of the role of inhibition of cyclic AMP in a2-adrenoceptor mediated contractions of the porcine isolated palmer lateral vein. Br. J. Pharmacol. 114:1995;157-165.
169. 1-adrenergic receptors in mediated by the alpha subunits of Gq family. J. Biol. Chem. 267:1992;25798-25802.
170. 2+. Br. J. Pharmacol. 98:1989;1032-1038.
171. 1D-adrenoceptors in the rabbit ventricular myocardium: analysis with BMY 7378. Br. J. Pharmacol. 122:1997;1541-1550.
172. Yoshimura N., de Groat W.C. Patch clamp analysis of afferent and efferent neurons that innervate the urinary bladder of the rat. Soc. Neurosci. Abstr. 18:1992;126.
173. 2B-adrenoceptor subtypes. Eur. J. Pharmacol. 168:1989;381-386.
174. 1B-adrenoceptors in phenylephrine induced positive inotropic response in isolated rat left atrium. J. Cardiovasc. Pharmacol. 24:1994;745-752.
175. Zeigler M.G., Lake C.R., Kopin I. Plasma noradrenaline increases with age. Nature. 261:1976;333-335.